![Frontiers | Direct oral anticoagulants in pediatric venous thromboembolism: Review of approved products rivaroxaban and dabigatran Frontiers | Direct oral anticoagulants in pediatric venous thromboembolism: Review of approved products rivaroxaban and dabigatran](https://www.frontiersin.org/files/Articles/1005098/fped-10-1005098-HTML/image_m/fped-10-1005098-g001.jpg)
Frontiers | Direct oral anticoagulants in pediatric venous thromboembolism: Review of approved products rivaroxaban and dabigatran
![Update on laboratory testing and hemostasis assessment in patients receiving direct oral anticoagulants (DOACs) - ScienceDirect Update on laboratory testing and hemostasis assessment in patients receiving direct oral anticoagulants (DOACs) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2666572721000535-gr1.jpg)
Update on laboratory testing and hemostasis assessment in patients receiving direct oral anticoagulants (DOACs) - ScienceDirect
![Dabigatran: Review of Pharmacology and Management of Bleeding Complications of This Novel Oral Anticoagulant | SpringerLink Dabigatran: Review of Pharmacology and Management of Bleeding Complications of This Novel Oral Anticoagulant | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13181-011-0178-y/MediaObjects/13181_2011_178_Fig1_HTML.gif)